Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Nanosonics Limited ( (AU:NAN) ) just unveiled an announcement.
UBS Group AG and its related bodies have become a substantial holder in Nanosonics Limited, with a 5.09% voting power through various branches and asset management entities. This development indicates a significant investment interest from a major financial institution, potentially impacting Nanosonics’ market positioning and stakeholder dynamics.
The most recent analyst rating on (AU:NAN) stock is a Hold with a A$2.75 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited operates in the healthcare industry, specializing in infection control solutions. The company is known for its innovative products that focus on preventing the spread of infections in healthcare settings.
Average Trading Volume: 996,085
Technical Sentiment Signal: Buy
Current Market Cap: A$1.24B
For a thorough assessment of NAN stock, go to TipRanks’ Stock Analysis page.